This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis
Leukemia Open Access 28 January 2019
-
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
Blood Cancer Journal Open Access 31 August 2018
-
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
Clinical Epigenetics Open Access 02 April 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Frohling S, Scholl C, Gilliland DG, Levine RL . Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 2005; 23: 6285–6295.
Kelly LM, Gilliland DG . Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002; 3: 179–198.
Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001; 29: 465–468.
Chen CY, Lin LI, Tang JL, Tsay W, Chang HH, Yeh YC et al. Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome. Leukemia 2006; 20: 1155–1158.
Chou WC, Tang JL, Lin LI, Yao M, Tsay W, Chen CY et al. Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Res 2006; 66: 3310–3316.
Chen CY, Lin LI, Tang JL, Ko BS, Tsay W, Chou WC et al. RUNX1 gene mutation in primary myelodysplastic syndrome—the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome. Br J Haematol 2007; 139: 405–414.
Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V et al. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 2006; 78: 279–290.
Acknowledgements
This work was sponsored partially by grants from the National Science Council of Taiwan, NSC 95-2314-B-002-243-MY2 and the Department of Medical Research at the National Taiwan University Hospital, Taiwan.
Author information
Authors and Affiliations
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Supplementary information
Rights and permissions
About this article
Cite this article
Hou, HA., Chou, WC., Lin, LI. et al. Characterization of acute myeloid leukemia with PTPN11 mutation: the mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD. Leukemia 22, 1075–1078 (2008). https://doi.org/10.1038/sj.leu.2405005
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2405005
This article is cited by
-
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
Bone Marrow Transplantation (2022)
-
The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia
Leukemia (2021)
-
Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia
Molecular Diagnosis & Therapy (2020)
-
Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis
Leukemia (2019)
-
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
Clinical Epigenetics (2018)